Abstract:OBJECTIVE:The study was designed to compare the pharmacokinetic parameters and relative bioavailability of a newly generic acipimox 250-mg tablets (test formulation) with a branded 250-mg tablets (reference formulation).METHODS:A single-dose, randomized-sequence, 2-way crossover study was conducted in 20 healthy Chinese male volunteers in the fasted state. Plasma samples were collected over 12 h after a single oral dose of 250-mg acipimox test or reference, followed by a 7-day washout period. Plasma concentrations of acipimox were analyzed by high-performance liquid chromatography. Drug And Statistical-Version 2.0 was used to calculate the pharmacokinetic parameters and assess bioequivalence of the 2 formulations. It is considered bioequivalent if the 90% CIs of the mean ratios (test: reference) for Cmax, AUC0-t and AUC0-∞ are all within the range from 80% to 125%.RESULTS:No period, formulation, or sequence effects were observed on any pharmacokinetic parameters. The main pharmacokinetic parameters for the test and reference were as follows: t1/2 were 1.412±0.168 h and 1.390±0.162 h; Tmax were 1.850±0.462 h and 1.800±0.571 h; Cmax were 4.035±1.055 μg · ml-1 and 3.858±0.986 μg · ml-1; AUC0-12 were 14.006±2.564 μg · ml-1 · h and 13.345±2.128 μg · ml-1 · h, and the AUC0-∞ were 14.147±2.568 μg · ml-1 · h and 13.486±2.117 μg · ml-1 · h. The 90% CIs for the ratios (test/reference) of Cmax, AUC0-12, and AUC0 - ∞ were 98.0-111.2%, 100.8-108.5%, and 100.8-108.3%, respectively.CONCLUSIONS:In this small study, a single 250-mg oral dose of an acipimox tablet (test formulation) is bioequivalent to the established reference formulation.

Pharmacokinetics of single dose ampiroxicam tablet in Chinese healthy subjects

Pharmacokinetics of multiple doses ampiroxicam in Chinese healthy subjects

Pharmacokinetics and Safety of Pitavastatin Calcium Tablets in Chinese Healthy Volunteers after a Single Oral Dose Administration

Exploring the pharmacokinetics and tolerability of cyclooxygenase inhibitor ampiroxicam: a phase I study on single and multiple oral doses

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Pharmacokinetics of single-dose astromicin sulfate in Chinese healthy volunteers

Pharmacokinetic characteristics of single-dose pidotimod injection in Chinese healthy volunteers

Pharmacokinetics of aranidipine enteric capsules in healthy Chinese volunteers

Pharmacokinetics Study of Lansoprazole for Injection in Chinese Healthy Volunteers

Pharmacokinetics of compound famotidine chewing tablets in Chinese healthy volunteers after a single oral dose administration

Pharmacokinetics of Compound Olmesartan Medoxomil and Hydrochlorothiazide Tablets in Chinese Healthy Volunteers

Study on Pharmacokinetics of Domestic Aripiprazole after Single and Multiple Dosing in Healthy Volunteers

Pharmacokinetic study of amlodipine besylate and folic acid tablet in Chinese healthy volunteers

Pharmacokinetics and Bioequivalence Evaluation of Two Acipimox Tablets: A Single-Dose, Randomized-Sequence, Two-Way Crossover Study in Healthy Chinese Male Volunteers

Pharmacokinetics of Prulifloxacin Tablets in Chinese Healthy Volunteers

Pharmacokinetics and Relative Bioavailability of a Generic Amisulpride Tablet in Healthy Chinese Volunteers

Pharmacokinetics of multiple-dose astromicin sulfate injection in Chinese healthy volunteers

Determination of lansoprazole in healthy human plasma by LC-MS/MS:application to pharmacokinetics study

Pharmacokinetic and Bioequivalence Evaluation of Dihydroxyaluminum Aminoacetate, Heavy Magnesium Carbonate, and Aspirin Tablets in Healthy Chinese Subjects in the Fasting and Postprandial Conditions

Pharmacokinetic and bioequivalence studies of ibuprofen suspension after a single-dose administration in healthy Chinese volunteers.

Pharmacokinetics of iloperidone tablets in healthy volunteers in China